Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Lex Pharmaceutical vitamin/OTC recall

This article was originally published in The Tan Sheet

Executive Summary

Lex Pharmaceutical vitamin/OTC recall: Medley, Fla.-based firm recalls 25,000 bottles of supplements and acetaminophen products at the behest of the Consumer Products Safety Commission because they do not have the required child-resistant packaging. The recalled products were packaged by Lex but some have other distributors. The products are: Multigon Junior vitamin mineral supplements for children and Duralgina acetaminophen tablets, distributed by Miami-based Menper Distributors; Cramps Out acetaminophen tablets, distributed by Efficient Labs of San Juan, Puerto Rico; Uni 1 Dose multi-vitamins with iron and Mematinic Beef-Iron and Wine supplement, distributed by Medley, Fla.-based Medley Pharmaceutical; Lexagran-M vitamins (Lex); and Supra-Vita vitamins (Carifarma Pharmaceutical, Rio Piedras, P.R.). They were sold at small pharmacies and discount drug and retail stores in Puerto Rico, New York, Florida and the southeastern U.S. states from January 1996 through June 1997. CPSC says it "is not aware of any injuries involving these products." Lex notes that the recall, begun in May, is complete...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel